AstraZeneca aims to produce 3 billion cans this year.
Oxford University has started a study to assess the safety and immune response of the COVID-19 vaccine, which it first developed in children with AstraZeneca Plc.
The new interim study will determine whether the vaccine is effective in people between the ages of 6 and 17, according to an email sent by the university via email.
Around 300 volunteers will be enrolled and first vaccinations are expected this month, Oxford said.
The two-dose Oxford / AstraZeneca vaccine has been named “Vaccine for the World” because it is cheaper and easier to distribute than some of its competitors.
AstraZeneca aims to produce 3 billion cans this year and to produce over 200 million cans per month by April.
(Except for the headline, this story was not edited by GossipMantri staff and published from a syndicated feed.)
